Oct 2, 2023 | Analysis
In a new white paper, Alex Brill details the consequences of regulatory uncertainty for businesses and provides a close look at the ongoing uncertainty facing companies owned by ESOPs.
Sep 26, 2023 | Analysis
MGA latest white paper, by CEO Alex Brill, looks at the role of pharmacy benefit managers (PBMs) in the US prescription drug market.
Jun 8, 2023 | Analysis
MGA’s state-by-state analysis of Community Health Centers’ economic impact.
May 24, 2023 | Analysis
MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.”
Feb 21, 2023 | Analysis, Press Releases
The Biosimilars Council released the following statement in response to the new MGA report authored by Alex Brill and Christy Robinson.
Jan 26, 2023 | Analysis
MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.”